- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.97 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 1XK: 4-[(3S)-3-cyclopropyl-3-(hydroxymethyl)-2-oxidanylidene-pyrrolidin-1-yl]-N-[[3-fluoranyl-5-(1-methylpyrazol-4-yl)phenyl]methyl]-6-methyl-pyridine-2-carboxamide(Non-covalent)
- 2 x PRO: PROLINE(Non-covalent)
PRO.2: 12 residues within 4Å:- Chain A: T.109, E.111, R.140, W.157, E.159, H.161, F.204, H.230, S.258, W.259, G.260
- Ligands: 1XK.1
10 PLIP interactions:9 interactions with chain A, 1 Ligand-Ligand interactions- Hydrophobic interactions: A:W.157, A:E.159
- Hydrogen bonds: A:T.109, A:T.109, A:S.258, P.2
- Water bridges: A:R.140, A:R.140
- Salt bridges: A:R.140, A:H.230
PRO.21: 12 residues within 4Å:- Chain B: T.109, E.111, R.140, W.157, E.159, H.161, F.204, H.230, S.258, W.259, G.260
- Ligands: 1XK.20
9 PLIP interactions:8 interactions with chain B, 1 Ligand-Ligand interactions- Hydrophobic interactions: B:W.157, B:E.159
- Hydrogen bonds: B:T.109, B:S.258, P.21
- Water bridges: B:R.140, B:R.140
- Salt bridges: B:R.140, B:H.230
- 6 x GOL: GLYCEROL(Non-functional Binders)
GOL.3: 4 residues within 4Å:- Chain A: E.243, K.251, R.252, L.253
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:K.251, A:L.253
GOL.4: 7 residues within 4Å:- Chain A: Y.28, Y.29, S.32, G.33, C.34, Y.35, P.146
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:Y.29, A:Y.29, A:G.33, A:C.34
GOL.5: 6 residues within 4Å:- Chain A: Y.35, M.37, T.152, F.155, L.156, T.263
6 PLIP interactions:6 interactions with chain A- Hydrogen bonds: A:Y.35, A:Y.35, A:L.156, A:T.263, A:T.263
- Water bridges: A:M.37
GOL.22: 4 residues within 4Å:- Chain B: E.243, K.251, R.252, L.253
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:K.251, B:L.253
GOL.23: 7 residues within 4Å:- Chain B: Y.28, Y.29, S.32, G.33, C.34, Y.35, P.146
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:Y.29, B:Y.29, B:G.33, B:C.34
GOL.24: 6 residues within 4Å:- Chain B: Y.35, M.37, T.152, F.155, L.156, T.263
7 PLIP interactions:7 interactions with chain B- Hydrogen bonds: B:Y.35, B:Y.35, B:L.156, B:T.263
- Water bridges: B:M.37, B:T.152, B:T.263
- 22 x CL: CHLORIDE ION(Non-functional Binders)
CL.6: 2 residues within 4Å:- Chain A: S.13, Y.500
Ligand excluded by PLIPCL.7: 3 residues within 4Å:- Chain A: K.198, Q.225, H.230
Ligand excluded by PLIPCL.8: 2 residues within 4Å:- Chain A: W.171, K.209
Ligand excluded by PLIPCL.9: 1 residues within 4Å:- Chain A: K.277
Ligand excluded by PLIPCL.10: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.11: 1 residues within 4Å:- Chain A: R.324
Ligand excluded by PLIPCL.12: 2 residues within 4Å:- Chain A: E.350, D.355
Ligand excluded by PLIPCL.13: 1 residues within 4Å:- Chain B: E.46
Ligand excluded by PLIPCL.14: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.15: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.16: 1 residues within 4Å:- Chain A: W.335
Ligand excluded by PLIPCL.25: 2 residues within 4Å:- Chain B: S.13, Y.500
Ligand excluded by PLIPCL.26: 3 residues within 4Å:- Chain B: K.198, Q.225, H.230
Ligand excluded by PLIPCL.27: 2 residues within 4Å:- Chain B: W.171, K.209
Ligand excluded by PLIPCL.28: 1 residues within 4Å:- Chain B: K.277
Ligand excluded by PLIPCL.29: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.30: 1 residues within 4Å:- Chain B: R.324
Ligand excluded by PLIPCL.31: 2 residues within 4Å:- Chain B: E.350, D.355
Ligand excluded by PLIPCL.32: 1 residues within 4Å:- Chain A: E.46
Ligand excluded by PLIPCL.33: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.34: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPCL.35: 1 residues within 4Å:- Chain B: W.335
Ligand excluded by PLIP- 2 x NA: SODIUM ION(Non-functional Binders)
- 2 x SO3: SULFITE ION(Non-covalent)
SO3.18: 7 residues within 4Å:- Chain A: F.42, W.45, Q.49, W.135, L.156
- Chain B: W.135
- Ligands: SO3.37
3 PLIP interactions:1 interactions with chain B, 2 interactions with chain A- Water bridges: B:W.135
- Hydrogen bonds: A:W.45, A:Q.49
SO3.37: 7 residues within 4Å:- Chain A: W.135
- Chain B: F.42, W.45, Q.49, W.135, L.156
- Ligands: SO3.18
3 PLIP interactions:2 interactions with chain B, 1 interactions with chain A- Hydrogen bonds: B:W.45, B:Q.49
- Water bridges: A:W.135
- 2 x ETA: ETHANOLAMINE(Non-covalent)
ETA.19: 9 residues within 4Å:- Chain A: Y.65, R.107, C.136, S.137
- Chain B: Y.65, R.107, C.136, S.137
- Ligands: ETA.38
4 PLIP interactions:2 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:R.107, A:S.137, B:Y.65, B:Y.65
ETA.38: 9 residues within 4Å:- Chain A: Y.65, R.107, C.136, S.137
- Chain B: Y.65, R.107, C.136, S.137
- Ligands: ETA.19
3 PLIP interactions:1 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:Y.65, B:R.107, B:S.137
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yogavel, M. et al., Targeting prolyl-tRNA synthetase via a series of ATP-mimetics to accelerate drug discovery against toxoplasmosis. Plos Pathog. (2023)
- Release Date
- 2022-09-07
- Peptides
- Prolyl-tRNA synthetase (ProRS): AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.97 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x 1XK: 4-[(3S)-3-cyclopropyl-3-(hydroxymethyl)-2-oxidanylidene-pyrrolidin-1-yl]-N-[[3-fluoranyl-5-(1-methylpyrazol-4-yl)phenyl]methyl]-6-methyl-pyridine-2-carboxamide(Non-covalent)
- 2 x PRO: PROLINE(Non-covalent)
- 6 x GOL: GLYCEROL(Non-functional Binders)
- 22 x CL: CHLORIDE ION(Non-functional Binders)
- 2 x NA: SODIUM ION(Non-functional Binders)
- 2 x SO3: SULFITE ION(Non-covalent)
- 2 x ETA: ETHANOLAMINE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yogavel, M. et al., Targeting prolyl-tRNA synthetase via a series of ATP-mimetics to accelerate drug discovery against toxoplasmosis. Plos Pathog. (2023)
- Release Date
- 2022-09-07
- Peptides
- Prolyl-tRNA synthetase (ProRS): AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
A